Clinical characteristics associated with falls in patients with non-metastatic castration-resistant prostate cancer treated with apalutamide (vol 26, pg 156, 2023)

被引：1
|
作者：
Pollock, Yaoyao
Smith, Matthew R.
Saad, Fred
Chowdhury, Simon
Oudard, Stephane
Hadaschik, Boris
Olmos, David
Lee, Ji Youl
Uemura, Hiroji
Bhaumik, Amitabha
Londhe, Anil
Rooney, Brendan
Brookman-May, Sabine D.
De Porre, Peter
Mundle, Suneel D.
Small, Eric J.
机构：
[1] University of California San Francisco,The Helen Diller Family Comprehensive Cancer Center
[2] Massachusetts General Hospital Cancer Center and Harvard Medical School,Georges Pompidou Hospital
[3] Centre Hospitalier de l’Université de Montréal,Spanish National Cancer Research Centre (CNIO)
[4] Université de Montréal,Department of Urology, Seoul St. Mary’s Hospital, College of Medicine
[5] Guy’s,undefined
[6] King’s and St. Thomas’ Hospitals,undefined
[7] Great Maze Pond,undefined
[8] University de Paris,undefined
[9] University of Duisburg-Essen,undefined
[10] Essen,undefined
[11] and Ruprecht-Karls-University Heidelberg,undefined
[12] Madrid and Biomedical Research Institute of Málaga (IBIMA),undefined
[13] The Catholic University of Korea,undefined
[14] Yokohama City University Medical Center,undefined
[15] Janssen Research & Development,undefined
[16] Janssen Research & Development,undefined
[17] Janssen Research & Development,undefined
[18] Ludwig-Maximilians-University,undefined
[19] Janssen Research & Development,undefined
[20] Janssen Research & Development,undefined
[21] St. Joseph Health Medical Group,undefined
[22] Providence St. Joseph Health,undefined
来源：
PROSTATE CANCER AND PROSTATIC DISEASES | 2023年 / 26卷 / 04期
关键词：
D O I：
10.1038/s41391-023-00683-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：813 / 813
页数：1
相关论文
共 50 条
  • [41] Re: Enzalutamide and Survival in Non-metastatic Castration-resistant Prostate Cancer
    Bagguley, Dominic
    Ong, Sean
    Lawrentschuk, Nathan
    Murphy, Declan G.
    EUROPEAN UROLOGY, 2021, 79 (02) : 320 - 321
  • [42] PREDICTORS OF TIME TO METASTASIS IN NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    Moreira, Daniel
    Howard, Lauren
    Sourbeer, Katie
    Kundich, Robert
    Kane, Christopher
    Aronson, William
    Terris, Martha
    Cooperberg, Matthew
    Amling, Christopher
    Freedland, Stephen
    JOURNAL OF UROLOGY, 2014, 191 (04): : E921 - E921
  • [43] Physician preferences for non-metastatic castration-resistant prostate cancer treatment
    Sandy Srinivas
    Ateesha F. Mohamed
    Sreevalsa Appukkuttan
    Marc Botteman
    Xinyi Ng
    Namita Joshi
    Erica Horodniceanu
    A. Reginald Waldeck
    Stacey J Simmons
    BMC Urology, 20
  • [44] Decisions and dilemmas in non-metastatic castration-resistant prostate cancer management
    Tartarone, Alfredo
    Lerose, Rosa
    Tartarone, Marina
    MEDICAL ONCOLOGY, 2022, 39 (07)
  • [45] PELVIC EXENTERATION IN PATIENTS WITH NON-METASTATIC, LOCALLY ADVANCED CASTRATION-RESISTANT PROSTATE CANCER
    Donahue, Timothy F.
    Morris, Michael J.
    Slovin, Susan F.
    Scher, Howard I.
    Scardino, Peter T.
    Bochner, Bernard H.
    JOURNAL OF UROLOGY, 2015, 193 (04): : E1038 - E1038
  • [46] Adverse events and costs among non-metastatic castration-resistant prostate cancer patients
    Appukkuttan, Sreevalsa
    Yao, Jianying
    Partridge, Jamie
    Kong, Sheldon X.
    Parkin, Jacqueline
    Freedland, Stephen J.
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 145 - 152
  • [47] Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
    Mori, Keiichiro
    Mostafaei, Hadi
    Pradere, Benjamin
    Motlagh, Reza Sari
    Quhal, Fahad
    Laukhtina, Ekaterina
    Schuettfort, Victor M.
    Abufaraj, Mohammad
    Karakiewicz, Pierre I.
    Kimura, Takahiro
    Egawa, Shin
    Shariat, Shahrokh F.
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (11) : 1892 - 1900
  • [48] Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
    Keiichiro Mori
    Hadi Mostafaei
    Benjamin Pradere
    Reza Sari Motlagh
    Fahad Quhal
    Ekaterina Laukhtina
    Victor M. Schuettfort
    Mohammad Abufaraj
    Pierre I. Karakiewicz
    Takahiro Kimura
    Shin Egawa
    Shahrokh F. Shariat
    International Journal of Clinical Oncology, 2020, 25 : 1892 - 1900
  • [49] Does docetaxel prolong survival of patients with non-metastatic castration-resistant prostate cancer?
    Ito, Kagenori
    Kimura, Takahiro
    Onuma, Hajime
    Tabata, Ryuji
    Shimomura, Tatsuya
    Miki, Kenta
    Tomita, Masayuki
    Egawa, Shin
    PROSTATE, 2018, 78 (07): : 498 - 505
  • [50] New treatments for patients with non-metastatic castration-resistant prostate cancer: A nursing perspective
    Olivier, Kara M.
    Floyd, Rebecca
    Smith, Matthew R.
    Shore, Neal D.
    Sutton, Jennifer
    INTERNATIONAL JOURNAL OF UROLOGICAL NURSING, 2021, 15 (02) : 47 - 58
12345